Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PTGX compared with RDNT: revenue, margins and what each company keeps, and the suppliers and customers both name
PTGX
Protagonist Therapeutics, Inc
Change
Mkt cap
Revenue
Revenue
RDNT
RadNet, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PTGX
Protagonist Therapeutics, Inc
vs
RDNT
RadNet, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PTGX, solid
RDNT, dashed
PTGX
Protagonist Therapeutics, Inc
Change
132.31
▼
−2.18%
· post 132.31
Mkt cap
$8.6B
Revenue
$274M
Q3 FY26
Revenue
$46M
FY25
RDNT
RadNet, Inc.
Change
75.83
▼
−2.79%
· post 75.83
Closed
Nov 6 '26
Mkt cap
$6.0B
Revenue
$623M
Q2 FY26
Revenue
$2.0B
FY25
vs
Compare
Closed
Nov 6 '26
PTGX
Protagonist Therapeutics, Inc
vs
RDNT
RadNet, Inc.
132.31
▼
−2.18%
post 132.31
Price
75.83
▼
−2.79%
post 75.83
$8.6B
Mkt cap
$6.0B
Q3 FY26
$274M
Revenue
$623M
Q2 FY26
FY25
$46M
Revenue
$2.0B
FY25
Change
Change
PTGX
132.31
▼
−2.18%
vs
RDNT
75.83
▼
−2.79%
Closed
Nov 6 '26